236 related articles for article (PubMed ID: 15815050)
1. Chryseobacterium indologenes non-catheter-related bacteremia in a patient with a solid tumor.
Christakis GB; Perlorentzou SP; Chalkiopoulou I; Athanasiou A; Legakis NJ
J Clin Microbiol; 2005 Apr; 43(4):2021-3. PubMed ID: 15815050
[TBL] [Abstract][Full Text] [Related]
2. A catheter-related bloodstream infection caused by Chryseobacterium indologenes successfully treated with antibiotic-lock rescue therapy.
Corbella M; Brandolini M; Cambieri P; Decembrino N; Pagani M; Bottazzi A; Muzzi A; Zecca M; Mariani B; Marone P
New Microbiol; 2017 Jul; 40(3):223-225. PubMed ID: 28675244
[TBL] [Abstract][Full Text] [Related]
3. Chryseobacterium indologenes bacteremia in an infant.
Douvoyiannis M; Kalyoussef S; Philip G; Mayers MM
Int J Infect Dis; 2010 Jun; 14(6):e531-2. PubMed ID: 19729329
[TBL] [Abstract][Full Text] [Related]
4. Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases.
Chen FL; Wang GC; Teng SO; Ou TY; Yu FL; Lee WS
J Microbiol Immunol Infect; 2013 Dec; 46(6):425-32. PubMed ID: 23022462
[TBL] [Abstract][Full Text] [Related]
5. Urinary tract infection by Chryseobacterium indologenes.
Bhuyar G; Jain S; Shah H; Mehta VK
Indian J Med Microbiol; 2012; 30(3):370-2. PubMed ID: 22885214
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with Chryseobacterium indologenes bacteremia in an intensive care unit.
Chou DW; Wu SL; Lee CT; Tai FT; Yu WL
Jpn J Infect Dis; 2011; 64(6):520-4. PubMed ID: 22116334
[TBL] [Abstract][Full Text] [Related]
7. Chryseobacterium indologenes subcutaneous port-related bacteremia in a liver transplant patient.
Shah S; Sarwar U; King EA; Lat A
Transpl Infect Dis; 2012 Aug; 14(4):398-402. PubMed ID: 22283924
[TBL] [Abstract][Full Text] [Related]
8. [Sepsis caused by Chryseobacterium indologenes in a patient with hydrocephalus].
Ceylan A; Güdücüoğlu H; Akbayram S; Bektaş A; Berktaş M
Mikrobiyol Bul; 2011 Oct; 45(4):735-40. PubMed ID: 22090305
[TBL] [Abstract][Full Text] [Related]
9. Chryseobacterium indologenes bacteremia in a bone marrow transplant recipient with chronic graft-versus-host disease.
Lin JT; Wang WS; Yen CC; Liu JH; Chiou TJ; Yang MH; Chao TC; Chen PM
Scand J Infect Dis; 2003; 35(11-12):882-3. PubMed ID: 14723368
[TBL] [Abstract][Full Text] [Related]
10. Noncatheter-related bacteraemia due to Chryseobacterium indologenes in an immunocompetent patient.
Baruah M; Lyngdoh C; Lyngdoh WV; Talukdar R
Indian J Med Microbiol; 2016; 34(3):380-1. PubMed ID: 27514966
[TBL] [Abstract][Full Text] [Related]
11. [Central intravenous catheter-related bacteremia due to Chryseobacterium indologenes after cord blood transplantation].
Kodama Y; Nishimura M; Nakashima K; Ito N; Fukano R; Okamura J; Inagaki J
Rinsho Ketsueki; 2013 Mar; 54(3):305-10. PubMed ID: 23676648
[TBL] [Abstract][Full Text] [Related]
12. Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia.
Lin YT; Jeng YY; Lin ML; Yu KW; Wang FD; Liu CY
J Microbiol Immunol Infect; 2010 Dec; 43(6):498-505. PubMed ID: 21195977
[TBL] [Abstract][Full Text] [Related]
13. Chryseobacterium indologenes bacteraemia in a preterm baby.
Sudharani V; ; Saxena NK
Indian J Med Microbiol; 2011; 29(2):196-8. PubMed ID: 21654125
[No Abstract] [Full Text] [Related]
14. Lumboperitonial shunt infection due to Chryseobacterium indologenes.
Al-Tatari H; Asmar BI; Ang JY
Pediatr Infect Dis J; 2007 Jul; 26(7):657-9. PubMed ID: 17596816
[TBL] [Abstract][Full Text] [Related]
15. Chryseobacterium indologenes bacteraemia in a diabetic child.
Cascio A; Stassi G; Costa GB; Crisafulli G; Rulli I; Ruggeri C; Iaria C
J Med Microbiol; 2005 Jul; 54(Pt 7):677-680. PubMed ID: 15947433
[TBL] [Abstract][Full Text] [Related]
16. Chryseobacterium Indologenes as a Novel Cause of Bacteremia in a Neonate.
Mirza IA; Khalid A; Hameed F; Imtiaz A; Ashfaq A; Tariq A
J Coll Physicians Surg Pak; 2019 Apr; 29(4):375-378. PubMed ID: 30925965
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia.
Huang YC; Lin YT; Wang FD
Int J Antimicrob Agents; 2018 Jan; 51(1):47-51. PubMed ID: 28668676
[TBL] [Abstract][Full Text] [Related]
18. Biofilm production, use of intravascular indwelling catheters and inappropriate antimicrobial therapy as predictors of fatality in Chryseobacterium meningosepticum bacteraemia.
Lin PY; Chen HL; Huang CT; Su LH; Chiu CH
Int J Antimicrob Agents; 2010 Nov; 36(5):436-40. PubMed ID: 20933186
[TBL] [Abstract][Full Text] [Related]
19. Transient bacteraemia due to Chryseobacterium indologenes in an immunocompetent patient: a case report and literature review.
Esposito S; Russo E; De Simone G; Gioia R; Noviello S; Vitolo M; Rega MR; Massari A; Posteraro L
J Chemother; 2015; 27(6):324-9. PubMed ID: 25096711
[TBL] [Abstract][Full Text] [Related]
20. Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan.
Lin YT; Chiu CH; Chan YJ; Lin ML; Yu KW; Wang FD; Liu CY
Scand J Infect Dis; 2009; 41(9):628-34. PubMed ID: 19579148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
